Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells

Overview of attention for article published in Cancer Cell International, October 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 1 X post from an account with 889 followers.

Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells. https://t.co/uzy0osvkUk

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.